Correlation Between Cytek Biosciences and Sight Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cytek Biosciences and Sight Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytek Biosciences and Sight Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytek Biosciences and Sight Sciences, you can compare the effects of market volatilities on Cytek Biosciences and Sight Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytek Biosciences with a short position of Sight Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytek Biosciences and Sight Sciences.

Diversification Opportunities for Cytek Biosciences and Sight Sciences

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cytek and Sight is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Cytek Biosciences and Sight Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sight Sciences and Cytek Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytek Biosciences are associated (or correlated) with Sight Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sight Sciences has no effect on the direction of Cytek Biosciences i.e., Cytek Biosciences and Sight Sciences go up and down completely randomly.

Pair Corralation between Cytek Biosciences and Sight Sciences

Given the investment horizon of 90 days Cytek Biosciences is expected to under-perform the Sight Sciences. But the stock apears to be less risky and, when comparing its historical volatility, Cytek Biosciences is 1.64 times less risky than Sight Sciences. The stock trades about -0.02 of its potential returns per unit of risk. The Sight Sciences is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  955.00  in Sight Sciences on January 8, 2025 and sell it today you would lose (746.00) from holding Sight Sciences or give up 78.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cytek Biosciences  vs.  Sight Sciences

 Performance 
       Timeline  
Cytek Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cytek Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward-looking signals remain somewhat strong which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Sight Sciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Sight Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in May 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cytek Biosciences and Sight Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cytek Biosciences and Sight Sciences

The main advantage of trading using opposite Cytek Biosciences and Sight Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytek Biosciences position performs unexpectedly, Sight Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sight Sciences will offset losses from the drop in Sight Sciences' long position.
The idea behind Cytek Biosciences and Sight Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated